Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of 1.09 trillion as of September 24, 2025. Its market cap has increased by 71.65% in one year.

Market Cap

1.09T

Enterprise Value

1.09T

Revenue

46.43B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,380.00

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 1.32B to 1.09T, an increase of 82,419.52%. That is a compound annual growth rate of 36.99%.

Market Cap History

Date	Market Cap	% Change
Sep 23, 2025	1,091.57B	72.60%
Dec 31, 2024	632.43B	55.74%
Dec 29, 2023	406.09B	-28.80%
Dec 30, 2022	570.31B	37.16%
Dec 31, 2021	415.79B	38.38%
Dec 31, 2020	300.47B	24.07%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	970.87B
Grupo Financiero Banorte	514.07B
Arca Continental	320.79B
Industrias Peñoles	310.68B
GMéxico Transportes	143.73B
FIBRA Prologis	114.24B
Fibra UNO	110.39B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	103.67B

Market Cap Rankings